$AFL — WATCHLIST 📊

$AFL — WATCHLIST 📊 Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. 🎯 Q1 FY26 | Rev $4B | EPS $1.75 vs $1.80 🔴 💡 Consensus expected steady earnings growth around $1.80, but the reported $1.75 is clouded by a $164M derivative gain, CECL provisions, and a prior-year net income outlier ($29M vs $1,019M), making true operating performance opaque. 📉 Reward/Risk: 0:1 🏢 Business Quality: 7/10 - Strong supplemental insurance franchise with high retention and cash generation, but current earnings noise and data discrepancies reduce confidence. 📊 Valuation: unclear — forward P/E ~16.7 appears above Aflac's 10-year median of ~12, but balance sheet data errors prevent reliable P/B or ROE triangulation;... Also in play: $EMR $ROK $ABB $HON $SIEGY $NUE

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S.